Scopus BioPharma  logo
Scopus BioPharma SCPS
$ 0.18 -48.37%

Quarterly report 2023-Q2
added 08-11-2023

report update icon

Scopus BioPharma Income Statement 2011-2024 | SCPS

Annual Income Statement Scopus BioPharma

2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011

Market Cap

3.8 M 12.5 M 137 M - - - - - - - - -

Shares

21.1 M 17.3 M 13.4 M - - - - - - - - -

Historical Prices

0.18 0.725 9.27 - - - - - - - - -

Net Income

-11.6 M -27 M -10.9 M -2.69 M -686 K - - - - - - -

Revenue

- - - - - - - - - - - -

Cost of Revenue

- - - - - - - - - - - -

Gross Profit

- - - - - - - - - - - -

Operating Income

-11.7 M -27.6 M -10.2 M -2.69 M - - - - - - - -

Interest Expense

- 775 K 706 K - - - - - - - - -

EBITDA

-11.7 M -27.6 M -10.2 M -2.69 M -686 K - - - - - - -

Operating Expenses

11.7 M 27.6 M 10.2 M - - - - - - - - -

General and Administrative Expenses

9.03 M 12.6 M 2.73 M 2.23 M 408 K - - - - - - -

All numbers in USD currency

Quarterly Income Statement Scopus BioPharma

2023-Q2 2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1

Shares

39.7 M 30.4 M 21.1 M 21.1 M 21.1 M 21.1 M 21.1 M 17.1 M 16.2 M 15.3 M 14.6 M 14 M 12.9 M 12.5 M 12.5 M 12.5 M - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Net Income

-2.62 M -2.68 M - -1.9 M -3.32 M -4.66 M - -1.4 M -15.6 M -3.41 M - -1.16 M -8.03 M -626 K - -797 K - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Revenue

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Cost of Revenue

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Gross Profit

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Operating Income

- - - -1.9 M -3.32 M -4.66 M - -2.76 M -15.3 M -3.07 M - -875 K -7.95 M -619 K - -797 K - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Interest Expense

- - - - - - - 111 K 332 K 332 K - 285 K 79.9 K 6.89 K - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

EBITDA

- - - -1.9 M -3.32 M -4.66 M - -2.76 M -15.3 M -3.07 M - -874 K -7.94 M -619 K - -797 K - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Operating Expenses

2.93 M 2.68 M - 1.9 M 3.32 M 4.66 M - 2.76 M 15.3 M 3.07 M - 875 K 7.95 M 619 K - 797 K - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

General and Administrative Expenses

936 K 1.07 M - 981 K 2.67 M 4.29 M - 2.68 M 1.73 M 1.82 M - 806 K 711 K 569 K - 715 K - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

All numbers in USD currency